UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Blood advances, 2021-01, Vol.5 (1), p.280-300

2021

Volltextzugriff (PDF)

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis

The Lancet (British edition), 2006-07, Vol.368 (9533), p.371-378

2006

Volltextzugriff (PDF)

Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays

Seminars in thrombosis and hemostasis, 2013-04, Vol.39 (3), p.272

2013

Volltextzugriff (PDF)

Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial

Critical care (London, England), 2018-05, Vol.22 (1), p.118-118, Article 118

2018

Volltextzugriff (PDF)

The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes

Transfusion (Philadelphia, Pa.), 2020-10, Vol.60 (10), p.2192-2198

2020

Volltextzugriff (PDF)

Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma

Leukemia & lymphoma, 2017-04, Vol.58 (4), p.941-949

2017

Volltextzugriff (PDF)

COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications

Critical reviews in oncology/hematology, 2021-12, Vol.168, p.103529-103529, Article 103529

2021

Volltextzugriff (PDF)

Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

Australian & New Zealand journal of obstetrics & gynaecology, 2012-02, Vol.52 (1), p.14-22

2012

Volltextzugriff (PDF)

Evaluation of Pre-analytical Variables in a Commercial Thrombin Generation Assay

Thrombosis research, 2014-07, Vol.134 (1), p.160-164

2014

Volltextzugriff (PDF)

International consensus recommendations on the management of people with haemophilia B

Therapeutic Advances in Hematology, 2022, Vol.13, p.20406207221085202-20406207221085202

2022

Volltextzugriff (PDF)

Initial treatment of venous thromboembolism

Circulation (New York, N.Y.), 2004-08, Vol.110 (9 Suppl 1), p.I3-I9

2004

Volltextzugriff (PDF)

Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)

Blood Research, 2023, 58(1), , pp.36-41

2023

Volltextzugriff (PDF)

The management of bleeding in patients receiving direct oral anticoagulants including the role of the new reversal agents

Pathology, 2017-02, Vol.49, p.S40-S40

McRae, Simon

2017

Volltextzugriff (PDF)

Diagnosis and management of adult patients with von Willebrand disease in South Australia

Seminars in thrombosis and hemostasis, 2011-07, Vol.37 (5), p.535

2011

Volltextzugriff (PDF)

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial

Thrombosis and haemostasis, 2008-03, Vol.99 (3), p.623

2008

Volltextzugriff (PDF)

Treatment options for venous thromboembolism: lessons learnt from clinical trials

Thrombosis journal, 2014-12, Vol.12 (1), p.27-27, Article 27

McRae, Simon

2014

Volltextzugriff (PDF)

Risk of Thrombosis in Patients Presenting with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)

TH open : companion journal to thrombosis and haemostasis, 2018-04, Vol.2 (2), p.e167-e172

2018

Volltextzugriff (PDF)

The Australian experience with switching to extended half‐life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.529-535

2020

Volltextzugriff (PDF)

Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?

Internal medicine journal, 2017-02, Vol.47 (2), p.225-227

2017

Volltextzugriff (PDF)

Issues with new oral anticoagulants-monitoring and management of bleeding

Pathology, 2014, Vol.46, p.S32-S32

McRae, Simon

2014

Volltextzugriff (PDF)

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

The New England journal of medicine, 2022-03, Vol.386 (11), p.1013-1025

2022

Volltextzugriff (PDF)

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

The New England journal of medicine, 2023-02, Vol.388 (8), p.694-705

2023

Volltextzugriff (PDF)

A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

The New England journal of medicine, 2013-05, Vol.368 (19), p.1771-1780

2013

Volltextzugriff (PDF)

Apixaban for Extended Treatment of Venous Thromboembolism

The New England journal of medicine, 2013-02, Vol.368 (8), p.699-708

2013

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(139)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis

Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays

Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial

The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes

Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma

COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications

Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

Evaluation of Pre-analytical Variables in a Commercial Thrombin Generation Assay

International consensus recommendations on the management of people with haemophilia B

Initial treatment of venous thromboembolism

Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)

The management of bleeding in patients receiving direct oral anticoagulants including the role of the new reversal agents

Diagnosis and management of adult patients with von Willebrand disease in South Australia

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial

Treatment options for venous thromboembolism: lessons learnt from clinical trials

Risk of Thrombosis in Patients Presenting with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)

The Australian experience with switching to extended half‐life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation

Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?

Issues with new oral anticoagulants-monitoring and management of bleeding

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

Apixaban for Extended Treatment of Venous Thromboembolism

Suchergebnisse filtern